Performance Drone Works (PDW), which last week received a conditional loan commitment from the Defense Department to supercharge its capacity and capabilities for making key drone components, expects ...

TOPEKA, Kan. (WIBW) - Topeka city leaders held a special meeting on Aug. 19 to learn more about the impact of data center development on infrastructure like utilities. While no public comment was ...

TOPEKA, Kan. (WIBW) - Topeka’s governing body is meeting with Compass Datacenters to go over questions about the company’s proposed development south of the city. The city announced a special work ...

Chris Crosby, Compass Datacenters CEO, joins 'Power Lunch' to discuss the recent pushback on data centers, the future of the AI buildout and much more. Got a confidential news tip? We want to hear ...

PDW Holdings has received a conditional loan commitment of up to $820 million from the U.S. Department of War’s Office of Strategic Capital to expand domestic manufacturing capacity for drones, ...

PDW Holdings, Inc. announced last week that it has received a conditional loan commitment of up to $820 million from the Department of War’s Office of Strategic Capital. PDW holdings is the parent ...

PDW plans to supply drone components with loan from Pentagon. Credit: PDW The Pentagon’s Office of Strategic Capital has made a conditional loan commitment of up to $820 million to Performance Drone ...

A House Judiciary subcommittee summoned Compass, the biggest real estate brokerage in the world, and the listing service Midwest Real Estate Data to answer questions about their partnership. By Aimee ...

North America volumes got a modest lift from soccer World Cup Business & Industry unit won over $2 billion in new contracts Company reiterates 2026 guidance that was upgraded in May July 21 (Reuters) ...

Evercore ISI on Wednesday upgraded Compass Pathways (CMPS) to Outperform from Inline and raised its price target to $21 from $8 after the U.K.-based biotech updated results from a late-stage trial ...

Compass Pathways (CMPS) added ~8% in early premarket trading on Tuesday after the U.K.-based biotech announced additional data from a second ongoing late-stage trial for its psychedelic therapy ...